Summary: Myoglobin (Μ τ 18 000) and fatty acid-binding protein (M r 15 000), are low molecular mass cytoplasmic proteins that are considered useful biochemical markers for early detection or exclusion of acute myocardial infarction, and also for early estimation of infarct size. As each of these proteins shows renal clearance, we studied the influence of renal function on the estimation of infarct size from their plasma concentration curves. For this, infarct size estimated from plasma myoglobin or fatty acid-binding protein release curves was compared with that estimated with the established infarct size markers hydroxybutyrate dehydrogenase and creatine kinase, which are not influenced by changes in renal function. The discordance between infarct size estimates was related to renal function.
Introduction
Myoglobin is a low molecular mass (M r 18000) non-
The serial measurement of cardiac proteins in blood and for monitoring of early detection of acute myocardial infarction, an earlier cardiac re P erfusion after thrombolytic therapy (6) (7) (8) .
estimation of infarct size would be of value for deter-Another small cardiac protein, heart-type fatty acidmining patient prognosis in an earlier stage, or for evalu-binding protein (M T 15 000) has also been proposed as ating in clinical studies the effect of therapeutic inter-an early marker for acute myocardial infarction (9) (10) (11) . ventions on infarct size. Fatty acid-binding protein is a cytoplasmic protein that serves as an intracellular carrier for fatty acids (12, 13) . Compared with high molecular mass cytoplasmic enzymes such as hydroxybutyrate dehydrogenase (EC 1.1.1.27; M T = 136000) or creatine kinase (EC 2.7.3.2; M T = 80 000), myoglobin and fatty acid-binding protein are more rapidly released into plasma, resulting in detectable increases in plasma as early as 2 h after the onset of coronary occlusion (6, 11) . Although myoglobin and fatty acid-binding protein are both present in heart as well as skeletal muscle cells, their different contents in these tissues and simultaneous release upon muscle injury allows the plasma ratio of myoglobin/fatty acidbinding protein to be used to discriminate myocardial (ratio = 4-6) from skeletal muscle injury (ratio = 20-70) (14, 15) .
For quantitative assessment of myocardial tissue damage from the plasma myoglobin or fatty acid-binding protein curve, the calculated cumulative release per liter plasma has to be divided by myoglobin or fatty acid-binding protein content per gram wet weight of tissue, so that myocardial injury can be expressed in gram equivalents of healthy myocardium per liter plasma (infarct size). To do so, it is required that the variations in cardiac tissue content among individuals be small. We demonstrated that the inter-individual variations in cardiac tissue content of fatty acid-binding protein and hydroxybutyrate dehydrogenase (about 15%) are smaller compared to the inter-individual variation of myoglobin content (about 25%) (16) .
In a recent study on the estimation of infarct size from plasma fatty acid-binding protein concentrations it was shown that the cumulative fatty acid-binding protein release, expressed as gram equivalents of healthy myocardium per liter plasma, yielded a comparable although slightly higher infarct size when estimated from fatty acid-binding protein compared to that estimated from hydroxybutyrate dehydrogenase plasma curves (11) . For myoglobin, it has been demonstrated that plasma levels are inversely related to the glomerular filtration rate (r = 0.62) and linearly related to serum creatinine (r = 0.63) in patients with renal disease (17) . Fatty acidbinding protein elevated plasma levels have also been found in the case of renal insufficiency (14, 18) . As a consequence, individual differences in renal function, or impairment of renal function after acute myocardial infarction, may complicate the quantitative use of myoglobin and also fatty acid-binding protein.
Therefore, the aims of the present study were
(1) to compare infarct size, estimated from plasma release curves of low molecular mass markers like myoglobin and fatty acid-binding protein, with infarct size estimated with the established infarct size markers hydroxybutyrate dehydrogenase and creatine kinase, and (2) to examine the influence of changes in renal clearance of myoglobin or fatty acid-binding protein on infarct size estimation.
For the latter the discordance between infarct size estimated from hydroxybutyrate dehydrogenase release, compared to infarct size estimated from myoglobin or fatty acid-binding protein release (Q my0 giobin/QHBDH or QFABP/QHBDH), was related to the mean plasma creatinine concentration during the first 24 hours after acute myocardial infarction.
Patients and Methods

Patients
Patients (17 men and 3 women, tab. 1) presented at the Department of Cardiology of the Hospital De Wever en Gregorius in Heerlen with chest pain and ST segment elevation typical of acute myocardial infarction within 6 hours after the onset of symptoms, were treated with thrombolytic therapy. First, 160 mg of acetylsalicylic acid (aspirin) was given (unless already given by a general practitioner or ambulance nurses), followed by thrombolytic therapy, which consisted of 1.5 million units of streptokinase, given by infusion in 40 min. Four hours after starting thrombolytic therapy heparin was given, 12 500 units subcutaneous, by every 12 hours, for 5 days. All procedures followed were approved by the Medical Ethical Committee of the Hospital.
All patients included had given informed consent. Fatty acid-binding protein was measured by a direct (one-step) non-competitive immunosorbent assay of the antigen capture type (sandwich ELISA) as described by Wodzig et al. (20) . Samples were diluted with phosphate buffered saline (pH 7.4) containing 1 g/1 bovine serum albumin and 0.5 g/1 Tween-20. The detection limit of the assay was 0.2 μ §/1. The recovery (mean ± SD) of purified human heart fatty acid-binding protein added in various quantities to control human plasma was 97 ± 5% (n = 12) in the intra-and inter-assay coefficient of variation were respectively 6.5% and 11%.
Creatinine was analyzed on a Beckman Synchron CX-7 system with Beckman reagents (testkit CREA 442760, Beckman Instruments Inc., Mijdrecht, The Netherlands). The method is based on a modified Jaffe method. In the reaction, creatinine combines with picrate in an alkaline solution to form a creatinine-picrate complex.
The system monitors the change in absorbance at 520 nm. Reference values were 71 -110 umol/1 in men, and in women 53-97 μηιοΐ/ΐ.
Calculation of cumulative protein release into plasma
The cumulative release of enzyme activity per liter of plasma from the onset of acute myocardial infarction (t = 0) up to time t, Q(t), was calculated with the following expression for a two-compartment model:
ο The three terms are the protein concentration in plasma, the extravasated protein concentration and the concentration eliminated from plasma, all three expressed per liter of plasma. C(t) is the plasma enzyme activity or protein concentration at time t, corrected by subtraction of the normal steady-state values C s . The fractional rate constants are for transcapillary escape (TER), extravascular return (ERR) and catabolism (FCR) of activity. This two-compartment model has been validated in the dog (21, 22) . Values for hydroxybutyrate dehydrogenase (HBDH) and creatine kinase (CK) estimated in man are (23) If the first plasma sample was obtained within 3 hours after the onset of symptoms, the corresponding enzyme activities were used for C s . In the remaining cases, fixed mean values of 100 U/l and 112 U/l were used for creatine kinase and hydroxybutyrate dehydrogenase, respectively.
Calculation of cumulative release of myoglobin and fatty acid-binding protein into plasma
Intravenously injected radiolabelled myoglobin shows rapid initial disappearance from plasma with a half-life of 10-20 min (24, 25) . However, it is known that the process of radiolabelling may significantly alter the biophysical characteristics of myoglobin and may consequently disturb the estimation of the serum half-life. It was verified that the disappearance rate is not altered in patients with acute myocardial infarction (26) . We used a two-compartment model for the calculation of the cumulative myoglobin and fatty acid-binding protein release. Using data on glomerular filtration rates in elderly adults (50-60 years) (27) and data on the extravasation and distribution of myoglobin (28, 29) 1 for hydroxybutyrate dehydrogenase and creatine kinase, transcapillary exchange of these small proteins is also much larger than for the large enzyme molecules, and therefore has an appreciable influence, especially on early plasma kinetics. This prompted us to also use a two-compartment model for the small protein molecules. If the first plasma sample was obtained within 3 hours after the onset of symptoms, the corresponding concentrations were used for C s . In the remaining cases, fixed mean values of 33 μg/l for myoglobin and 2 μg/l for fatty acid-binding protein were used. Samples with myoglobin concentrations below 50 μg/l, the detection limit of the assay, were also indicated as 33 μg/l, the mean reference value for myoglobin using a radioimmunoassay.
Expression of myocardial injury in gram-equivalents of tissue per liter of plasma
To express myocardial injury in gram-equivalents heart muscle per liter of plasma, the cumulative release of cardiac enzymes or proteins per litre of plasma was divided by the respective enzyme or protein content per gram wet weight of healthy myocardium. Creatine kinase, hydroxybutyrate dehydrogenase, fatty acid-binding protein and myoglobin contents per gram wet weight as determined in an earlier study of our group were respectively 2163 U/g, 156 U/g, 0.57 mg/g and 2.79 mg/g wet weight (16) .
Statistics and data presentation
Release curves of proteins into plasma are presented as mean ± SEM for the sake of clarity. Pearson's correlation coefficient was calculated to show relations between different parameters. A t-test for independent samples was used to assess statistically significant differences. The level of significance was set at p < 0.05.
Results
Mean concentration in plasma and mean cumulative release
Mean plasma concentrations or activities of the proteins examined as a function of time for all 20 patients (fig. la) showed a marked difference between the plasma kinetics of fatty acid-binding protein and myoglobin when compared to those of creatine kinase and hydroxybutyrate dehydrogenase. For both fatty acid-binding protein and myoglobin two peaks were seen in the mean plasma release curve. Within 24 hours the plasma concentration of both fatty acid-binding protein and myoglobin had returned to normal, whereas it took 50-70 hours for creatine kinase and more than 70 hours for hydroxybutyrate dehydrogenase.
The cumulative release patterns of the four proteins, expressed in gram equivalents of tissue per litre of plasma showed a large difference between fatty acid-binding protein and myoglobin compared to creatine kinase and hydroxybutyrate dehydrogenase ( fig. Ib) . Release of fatty acid-binding protein and myoglobin were completed much earlier, but mean infarct size estimates obtained from myoglobin or fatty acid-binding protein were almost twice the infarct size estimated from creatine kinase and hydroxybutyrate dehydrogenase plasma release curves.
As the low molecular mass proteins fatty acid-binding protein and myoglobin are eliminated from plasma by renal clearance, their plasma concentrations are influenced by changes in glomerular filtration rate. Therefore, the discordance between infarct size estimated from plasma creatine kinase or hydroxybutyrate dehydrogenase release, compared to infarct size estimated from plasma myoglobin or fatty acid-binding protein release might be caused by changes in renal function.
Influence of renal function
To examine the influence of possible changes or interindividual differences in renal function, plasma creatinine concentrations were measured in all plasma samples. Especially during the first hours after acute myocardial infarction, haemodynamic changes introduce variations in the plasma creatinine concentration. Therefore, the mean plasma creatinine concentration was estimated from plasma creatinine concentrations measured in all samples (9-12) taken during the first 24 hours after acute myocardial infarction. On the basis of the mean creatinine concentrations during the first 24 hours, the patients were divided into two groups (tab. 1). Patients with a mean creatinine concentration below the upper reference limit, below 110 μηιοΙ/1 for men and 97 μπιοΙ/1 for women, i. e. normal renal clearance (group 1) and patients whith a mean creatinine concentration above the upper reference limit for creatinine, abnormal renal clearance (group 2). Figure 2 shows the mean plasma creatinine concentrations as a function of time for these two patient groups.
The ratios between infarct size estimated from cumulative myoglobin or fatty acid-binding protein release and infarct size estimated from cumulative hydroxybutyrate dehydrogenase release (Q my ogiobin/QHBDH, fig· 3a or QFABP/QHBDH? fig· 3b), was found to be related to the mean creatinine concentration in samples taken during the first 24 hours after acute myocardial infarction. Thus, for patients with mean creatinine concentrations above the upper reference level, infarct sizes as determined from myoglobin or fatty acid-binding protein are severely overestimated. This appears to hold especially for the larger infarcts (tab. 1).
Cumulative release of the different cardiac markers
Mean cumulative release was again calculated after elimination of patients with mean creatinine concentrations above the upper reference limit of creatinine (group 2, η = 5). Figure 4 shows the mean plasma creatine kinase and hydroxybutyrate dehydrogenase activities and the mean fatty acid-binding protein and myoglobin concentrations as a function of time in patients with normal renal function (group l, n = 15). After elimina- 
Discussion
Quantitation of infarct size from serial plasma myoglobin on fatty acid-binding protein concentrations
Size estimation of myocardial infarction from serial serum myoglobin concentrations was first performed by Groth et al. (30) . In that study a reasonable correlation (r = 0.72) was found between the myoglobin estimates of infarct size compared to the creatine kinase-MB estimates of infarct size. Grottum et al. found a reasonable correlation (r = 0.72) between infarct size estimates from creatine kinase and myoglobin plasma curves (31) . The authors suggested myoglobin as an early marker for estimation of infarct size, because creatine kinase release starts 3-5 hours after acute myocardial infarction, whereas myoglobin release generally starts earlier and is already completed within 24 h after acute myocardial infarction. In both studies infarct size was not expressed in gram equivalents of healthy myocardium per litre plasma (g-eq/1) and therefore quantitative comparison of infarct size measures obtained with creatine kinase, creatine kinase-MB and myoglobin was not possible.
In the present study infarct size, estimated from plasma curves of different cardiac markers was expressed in gram equivalents of healthy cardiac tissue, using cardiac tissue contents estimated in an earlier study (16) . This allowed us to quantitatively compare the infarct size measures obtained with the different cardiac markers. We compared infarct size estimates obtained from plasma release curves of low molecular mass markers like myoglobin or fatty acid-binding protein, with infarct size estimates obtained with the established infarct size markers creatine kinase and hydroxybutyrate dehydrogenase.
Sources of error in infarct size estimation
Influence of renal function on estimation of infarct size
The plasma release curves of myoglobin and fatty acidbinding protein showed a completely similar pattern and suggest that both myoglobin and fatty acid-binding protein are released from the heart and cleared from the bloodis -F stream essentially in the same manner. In view of their low molecular masses, it is most likely that myoglobin (M T 18 000) as well as fatty acid-binding protein (M r 15 000) are eliminated from the circulation mainly by renal clearance (2, 32) . Indeed, both proteins have been found in urine from patients with acute myocardial infarction (9, 10, 33) . For myoglobin, it has been demonstrated that plasma concentrations are inversely related to the glomerular filtration rate and linearly related to the serum creatinine concentration in 68 patients with renal disease (17) . For fatty acid-binding protein elevated plasma levels have also been found in the case of renal insufficiency (14, 18 Cr-EDTA clearance was measured in 10 patients immediately after acute myocardial infarction and three weeks later (35) . This implies that individual differences in renal clearance of these low molecular mass proteins will cause error in calculated infarct size. We measured plasma creatinine in all samples taken during the first 72 hours after acute myocardial infarction. Due to haemodynamic and plasma volume changes during the first hours after the onset of symptoms, considerable intra-individual variation in plasma creatinine concentration can occur. As cumulative fatty acid-binding protein and myoglobin release were completed within 24 hours (see fig. Ib and  fig. 4b ), mean plasma creatinine was calculated from samples taken during the first 24 hours only. We found a relation between mean plasma creatinine during the first 24 hours after acute myocardial infarction and the discordance between infarct size estimated from low molecular mass cardiac markers fatty acid-binding protein and myoglobin, as compared to the high molecular mass marker hydroxybutyrate dehydrogenase.
For patients with normal mean creatinine concentrations during the first 24 hours after acute myocardial infarction there is a good correlation between infarct size estimated from plasma myoglobin or fatty acid-binding protein release and infarct size estimated with the established infarct size marker hydroxybutyrate dehydrogenase. For patients with increased creatinine concentrations, estimation of infarct size from plasma myoglobin or fatty acid-binding protein curves can be severely overestimated (especially for larger infarcts).
Serum creatinine alone is of course not the ideal marker to express renal function, but it appeared sufficient to eliminate patients with severe disturbance of glomerular filtration. As we did not measure body weight of the individual patients, we were not able to make a more precise estimate of creatinine clearance. It is to be expected that the correlation between creatine clearance and cumulative fatty acid-binding protein or myoglobin release will be even stronger than it is with mean serum creatinine concentration.
Sampling scheme
It has been shown that plasma myoglobin levels after acute myocardial infarction behave rather erraticly, the so-called staccato phenomenon (36) . For a frequent sampling schedule, the isolated "spikes" will contribute little to the curve area and will tend to cancel. As the sampling becomes sparser, however, an accidental high or low value may introduce considerable error and this effect could be enhanced in patients treated with thrombolytic therapy, because of the accelerated release observed after such therapy. Therefore, accurate quantification of infarct size from plasma myoglobin or fatty acid-binding protein curves is more reliable from frequently sampled plasma curves.
Variation in cardiac tissue content
The variation in myocardial myoglobin content is about 25% and is larger than the values of about 15% found for fatty acid-binding protein and hydroxybutyrate dehydrogenase (16) . In the present study the scatter of infarct size calculated from plasma myoglobin or fatty acidbinding protein curves, compared to infarct size estimated from plasma hydroxybutyrate dehydrogenase curves was comparable.
Complete recovery of myoglobin and fatty acid-binding protein Quantitative recovery of cytoplasmic proteins in plasma after ischaemic myocardial damage has been demonstrated in experimental studies. The total quantity of myoglobin depleted from dog heart after 2 hours of coronary occlusion (37) , and the total activities of creatine kinase and hydroxybutyrate dehydrogenase depleted from dog heart after permanent occlusion (38) , equalled the calculated release of these proteins in plasma. The similarity of estimates of injury for the different cardiac markers, shown in figure 4b, supports these demonstrations of complete recovery. Incomplete recovery could only be compatible with the results shown in figure 4b if infarcted domains existed in which all proteins remain confined and are totally prevented from reaching the circulation.
In summary, the present study shows that estimation of infarct size from serial plasma myoglobin or fatty acidbinding protein concentrations is possible in the first 24 hours after the onset of symptoms, but only in patients with normal plasma creatinine concentrations during this period. For these patients a good agreement was found between infarct size estimated from the cumulative plasma hydroxybutyrate dehydrogenase release and infarct size estimated from the cumulative myoglobin or fatty acid-binding protein release.
